Supplement to the Annual Report of the Board for 2022 on the Availability of Internationally Controlled Substances
No Patient Left Behind: Progress in Ensuring Adequate Access to Internationally Controlled Substances for Medical and Scientific Purposes
Versandkostenfrei!
Versandfertig in über 4 Wochen
26,99 €
inkl. MwSt.
PAYBACK Punkte
13 °P sammeln!
Andere Kunden interessierten sich für
